Company: VEEAW
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001213900-25-002701
Chunk: 44

Company: VEEA INC.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 44
---
’s success in obtaining and enforcing patent claims that cover all of Veea’s technology, inventions and improvements.
With respect to both licensed and company-owned intellectual property, Veea cannot be sure that patents will be granted with respect
to any of Veea’s pending patent applications or with respect to any patent applications filed by us in the future. Moreover, even
issued patents do not provide Veea with the right to practice Veea’s technology in relation to the commercialization of Veea’s
products. Third parties may have blocking patents that could be used to prevent us from commercializing Veea’s products and practicing
Veea’s proprietary technology. Veea’s issued patent as well as patents that may issue in the future that Veea owns or licenses
may be challenged, invalidated, or circumvented, which could limit Veea’s ability to stop competitors from marketing related products
or limit the length of the term of patent protection that Veea may have for Veea’s products. Furthermore, Veea’s competitors
may independently develop similar technologies.

Additionally, issuance of a patent is not conclusive
as to its inventorship, scope, validity, or enforceability, and Veea’s patents may be challenged in the courts or patent offices
in the U.S. and abroad. Veea may be subject to a third-party pre-issuance submission of prior art to the U.S. Patent and Trademark Office
(“USPTO”) or in other jurisdictions, or become involved in opposition, derivation, revocation, reexamination,
post-grant and inter partesreview, or other similar proceedings challenging Veea’s patent rights. An adverse determination
in any such submission, proceeding or litigation could reduce the scope of, invalidate or render unenforceable, Veea’s patent rights,
allow third parties to commercialize Veea’s products and other proprietary technologies Veea may develop and compete directly with
Veea, without payment to Veea, or result in Veea’s inability to manufacture or commercialize products without infringing third-party
patent rights. Such proceedings also may result in substantial cost and require significant time from Veea’s scientists and management,
even if the eventual outcome is favorable to us.

In addition, if the breadth or strength of protection
provided by Veea’s patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating
with Veea to license, develop or commercialize current or future products.

<div align='center'>17</div>

Veea